Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
Move to accelerate cancer care expansion across India
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Move strengthens footprint in Western India and expands multi-specialty care network
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
Subscribe To Our Newsletter & Stay Updated